the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
26 May 2024 – Semaglutide is the active ingredient in the three Novo Nordisk drugs Ozempic, Rybelsus, and Wegovy that are being used for weight loss purposes. Thus, Ozempic, which was approved in 2017 by the FDA as a Type 2 diabetes treatment, …
Severe Stomach Conditions in Patients taking Semaglutide Read more »
May 06, 2024 – Non-Hispanic persons of African ancestry typically have worse clinical outcomes from colorectal cancer (CRC) than individuals of other heritages, a disparity attributed to many factors, including socioeconomic, environmental, and genetic influences, as well as less access …
March 27, 2024 – Lyrica (Pregabalin) is a drug from the group of gabapentinoids and is an anticonvulsant active ingredient. It has been approved throughout the EU since 2004 for the treatment of neuropathic pain, epilepsy and generalized anxiety disorder. …
March 15, 2024 – On the occasion of International Rare Disease Day on February 28, the Swiss Foundation for People with Rare Diseases drew attention to the current challenges and needs of those affected. In Europe, a disease is considered …
Rare diseases: No diagnosis or the most expensive drug in the world? Read more »
March 04, 2024 – People have been looking for ways to get rid of multi-resistant germs for many years. US researchers at Harvard University have developed a new antibiotic that is effective against a variety of resistant bacteria. The results …
Multi-resistant bacteria: New antibiotic destroys hospital germs Read more »
03 January 2024 – 23andMe is a personal genomics company out of South San Francisco, It is best known for providing a direct-to-consumer (DTC) genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism …
December 29, 2023 – Alzheimer’s disease is a neurodegenerative human disease that occurs in its most common form in people over the age of 65 and is characterized by increasing dementia. It is responsible for approximately 60 percent of the …
Alzheimer’s: Are we at the beginning of a new era of treatment? Read more »
21 December 2023 – Finasteride is a medication used for the treatment of benign prostatic hyperplasia (on the market as Proscar (5mg) since 1992 for this indication) and male pattern hair loss (on the market as Propecia (1mg) since 1997 for this indication). Finasteride is a type II and type III 5α-reductase inhibitor, 5α-reductase …
Post-Finasteride Syndrome Patients: Is There Differential Gene Expression? Read more »
December 11, 2023 – In June of 2021, the American Food and Drug Administration (FDA) approved the drug semaglutide for chronic weight management under the brand name Wegovy, ushering in a new era of obesity treatment. Since then, demand for …
Semaglutide Popularity: Serious Rare Adverse Effects Are Emerging Read more »
05 December 2023 – PDD, meaning persistent depressive disorder (dysthymia) may be underlaying this indifferently lingering “Meh” feeling we all may have or are living through at times. “Meh” is a colloquial interjection used as an expression of indifference or boredom. It is …
PDD: Are we all suffering from it? In one way or the other? Read more »